Staged Surgical Palliation for HLHS in a Girl with Severe Factor X Deficiency

Abstract

Background Factor X deficiency (also known as Stuart–Prower factor deficiency) is an autosomal recessive extremely rare hereditary hematologic disorder, affecting around 1:1,000,000 of the general population.

Case Presentation This case report describes a patient with hypoplastic left heart syndrome and severe factor X deficiency, who underwent staged surgical palliation. From stage 1 Norwood palliation, through superior cavopulmonary anastomosis and ending with total cavopulmonary connection with satisfactory hemostasis and no significant perioperative bleeding complication.

Conclusion The need to maintain hemostasis while aiming to prevent intracardiac thrombosis requires multidisciplinary team approach including hematologist, cardiac surgeon, pediatric cardiac intensivist, and anesthesiologist along with meticulous hemostasis during surgery and careful monitoring of coagulation profile in the postoperative period.

Keywords

factor X deficiency - hypoplastic left heart syndrome - Norwood procedure - superior cavopulmonary anastomosis - total cavopulmonary connection

• References

• 1 Horlocker TT, Wedel DJ, Rowlingson JC. , et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (3rd ed.). Reg Anesth Pain Med 2010; 35 (01) 64-101
• 2 Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008; 14 (06) 1176-1182
• 3 Bolton-Maggs PHB, Perry DJ, Chalmers EA. , et al. The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10 (05) 593-628
• 4 Peyvandi F, Mannucci PM, Lak M. , et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102 (02) 626-628
• 5 Thompson CA, Kyle R, Gertz M, Heit J, Pruthi R, Pardanani A. Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol 2010; 85 (03) 171-173
• 6 Knight RD, Barr CF, Alving BM. Replacement therapy for congenital factor X deficiency. Transfusion 1985; 25 (01) 78-80